Seite - (000147) - in Biomedical Chemistry: Current Trends and Developments

Rothermundt, M., Arolt, V., Fenker, J., Gutbrodt, H., Peters, M., & Kirchner, H. (2001). Different immune patterns in melancholic and non-melancholic major depression. European Archives of Psychiatry and Clinical Neuroscience, 251(2), 90-97. Sapolsky, R. M. (1985). A mechanism for glucocorticoid toxicity in the hippocampus: increased neuronal vulnerability to metabolic insults. Journal of Neuroscience, 5(5), 1228-1232. Schaefer, M., Horn, M., Schmidt, F., Schmid-Wendtner, M. H., Volkenandt, M., Ackenheil, M., Schwarz, M. J. (2004). Correlation between sICAM-1 and depressive symptoms during adjuvant treatment of melanoma with interferon-alpha. Brain, Behavior, and Immunity, 18(6), 555-562. doi: 10.1016/j.bbi.2004.02.002 Schulte, H. M., Chrousos, G. P., Avgerinos, P., Oldfield, E. H., Gold, P. W., Cutler, G. B., Jr., & Loriaux, D. L. (1984). The corticotropin-releasing hormone stimulation test: a possible aid in the evaluation of patients with adrenal insufficiency. Journal of Clinical Endocrinology & Metabolism, 58(6), 1064-1067. doi: 10.1210/jcem-58-6-1064 Scott, K. M., Von Korff, M., Ormel, J., Zhang, M. Y., Bruffaerts, R., Alonso, J., Haro, J. M. (2007). Mental disorders among adults with asthma: results from the World Mental Health Survey. General Hospital Psychiatry, 29(2), 123-133. doi: 10.1016/j.genhosppsych.2006.12.006 Seidel, A., Arolt, V., Hunstiger, M., Rink, L., Behnisch, A., & Kirchner, H. (1996). Major depressive disorder is associated with elevated monocyte counts. Acta Psychiatrica Scandinavica, 94(3), 198-204. Sluzewska, A., Rybakowski, J. K., Laciak, M., Mackiewicz, A., Sobieska, M., & Wiktorowicz, K. (1995). Interleukin-6 serum levels in depressed patients before and after treatment with fluoxetine. Annals of the New York Academy of Sciences, 762, 474-476. Smith, E. E., & Jonides, J. (1999). Storage and executive processes in the frontal lobes. Science, 283(5408), 1657-1661. Smith, G. W., Aubry, J. M., Dellu, F., Contarino, A., Bilezikjian, L. M., Gold, L. H., Lee, K. F. (1998). Corticotropin releasing factor receptor 1-deficient mice display decreased anxiety, impaired stress response, and aberrant neuroendocrine development. Neuron, 20(6), 1093-1102. Snyder, K., Wang, W. W., Han, R., McFadden, K., & Valentino, R. J. (2012). Corticotropin-releasing factor in the norepinephrine nucleus, locus coeruleus, facilitates behavioral flexibility. Neuropsychopharmacology, 37(2), 520-530. doi: 10.1038/npp.2011.218 Steptoe, A., Hamer, M., & Chida, Y. (2007). The effects of acute psychological stress on circulating inflammatory factors in humans: a review and meta-analysis. Brain, Behavior, and Immunity, 21(7), 901-912. doi: 10.1016/j.bbi.2007.03.011 Sullivan, P. F., Daly, M. J., & O’Donovan, M. (2012). Genetic architectures of psychiatric disorders: the emerging picture and its implications. Nature Reviews Genetics, 13(8), 537- 551. doi: 10.1038/nrg3240 Szuster-Ciesielska, A., Tustanowska-Stachura, A., Slotwinska, M., Marmurowska-Michalowska, H., & Kandefer-Szerszen, M. (2003). In vitro immunoregulatory effects of antidepressants in healthy volunteers. Polish Journal of Pharmacology, 55(3), 353-362. Tempier, R., Meadows, G. N., Vasiliadis, H. M., Mosier, K. E., Lesage, A., Stiller, A., Lepnurm, M. (2009). Mental disorders and mental health care in Canada and Australia: comparative epidemiological findings. Social Psychiatry and Psychiatric Epidemiology, 44(1), 63-72. doi: 10.1007/s00127-008-0409-y Veith, R. C., Lewis, N., Langohr, J. I., Murburg, M. M., Ashleigh, E. A., Castillo, S. (1993). Effect of desipramine on cerebrospinal fluid concentrations of corticotropin-releasing factor in